It has helped to expand access to critical prescription drugs at a price point that patients can afford, while opening up opportunities for innovation in other areas like Medicare and Medicaid
In their article, the researchers detail how these medications can both directly and indirectly reduce liver fat, inflammation, and fibrosis, potentially improving disease outcomes
Tirzepatide (dual GIP/GLP-1 agonist, not yet formally approved for obesity in the EU): in the SURMOUNT-1 study, resulted in an average weight loss of up to 22.5% at 72 weeks with the 15 mg weekly dose, approaching the effectiveness observed with some bariatric procedures
Drip and Glow IV Therapy Reveal radiant, glowing skin from within with our signature Drip & Glow IV
Understanding the importance of accurate dosing is crucial for effective treatment, and we want to emphasize that incorrect dosing could lead to ineffective results or unwanted side effects
Learn more about how much water to drink on a GLP-1 if you want a deeper breakdown of hydration habits that support treatment